Our data suggested quercetin could induce the expression and activation of UCP1 in both BAT and WAT to generate metabolic improvements in MetS mice, which implied that quercetin might be a promising drug to activate human BAT against metabolic disorders, but further clinical validation was required. Here, UCP1 is linked to metabolic syndrome.